Fundraise

Symbiotec Pharmalab draws Rs 648 crore in secondary deal days before IPO

What's the deal? A group of investors including Think India Opportunities Master FundDealroom has a profile for this one. Try Dealroom →, ValueQuest Investment AdvisorsDealroom has a profile for this one. Try Dealroom →, and WhiteOak Capital Asset ManagementDealroom has a profile for this one. Try Dealroom → picked up a 10.4% stake in Symbiotec Pharmalab for Rs 647.89 crore (roughly $67.8 million) through a secondary share transaction. The deal, executed on August 19, saw 6.557 million shares change hands at Rs 988 apiece.

Who's buying and selling? Alongside the lead buyers, Dymon Asia Multi-Strategy Investment, Singularity Equity Fund IDealroom has a profile for this one. Try Dealroom →, Waterfield Flagship Fund I, and Landmark Capital Markets joined the round. On the sell side, Rosewood Private InvestmentsDealroom has a profile for this one. Try Dealroom → transferred shares worth about Rs 275 crore, while Motilal Oswal Private EquityDealroom has a profile for this one. Try Dealroom →-backed India Business Excellence Fund-IIIDealroom has a profile for this one. Try Dealroom → offloaded stock valued at Rs 372.89 crore.

Why now? The transaction lands just days before the Indore-based drugmaker's Rs 1,757-crore IPO, which opens for subscription on August 24 and closes on August 27. Anchor investors bid on August 21.

What's the endgame? The shares priced at Rs 988 — the top of the IPO's Rs 938-988 band, which values Symbiotec at around Rs 6,350 crore. The public issue comprises a fresh issue worth up to Rs 150 crore and an offer-for-sale of up to Rs 1,607 crore, under which promoter Satwani Holdings LLPDealroom has a profile for this one. Try Dealroom →, Rosewood Private Investments, and India Business Excellence Fund-III will sell shares.

The signal: Institutional buyers locking in a stake at the top of the price band ahead of listing points to firm demand for the pharmaceutical maker — and hands existing backers an early exit at IPO terms.

Read more: Dailyhunt (PTI)

Image credit: Monash Public Library Service

More top stories